生物标记发现外包服务市场规模、份额、趋势分析报告：按生物标记类型、治疗领域、阶段、最终用途、地区和细分市场进行预测，2025 年至 2030 年

生物标誌物发现外包服务市场的成长和趋势

根据 Grand View Research, Inc. 的一份新报告，全球生物标记发现外包服务市场预计到 2030 年将达到 412.7 亿美元，2025 年至 2030 年期间的复合年增长率为 19.4%。

由于生物标记在临床试验中的应用越来越多，以及製药公司外包速度加快，生物标记研究的外包不断增长，是该市场的主要成长要素。

此外，液态切片的普及也有望推动市场成长。液态切片可以分析血液、尿液和脑脊髓液等体液中的生物标记物，与传统组织切片检查相比，它具有多种优势，包括侵入性较小、可以即时提供资讯。因此，液态切片的应用正在迅速增长，这一趋势直接影响了对生物标记发现外包服务的需求。

预计体学技术的进步将在未来几年推动市场成长。基因组学、蛋白质组学、代谢体学和其他体学技术的进步使得人们能够识别新的生物标记。整合多个体学部分的资料通常有利于生物标记的识别。专门从事多体学资料整合的外包服务为此领域提供了宝贵的专业知识。

药物开发和临床测试的增加是推动市场成长的主要因素。生物标记在药物开发中发挥关键作用，可帮助製药公司确定合适的药物目标、简化临床测试流程并选择进行测试的患者群体。截至 2023 年，全球临床试验状况显示，ClinicalTrials.gov 上註册了 452,604 项临床试验，其中 64,838 名积极招募参与者。与 2021 年初记录的约 365,000 次註册测试相比，这是一个显着的增长，支撑了临床研究领域的强劲和持续增长。

生物标誌物发现外包服务市场报告重点

• 根据生物标记类型，替代终点部分在 2024 年占据最大收入份额，为 54.88%。
• 依治疗领域，分为肿瘤学、神经病学、循环系统、自体免疫疾病等。
• 按阶段划分，生物标记识别部分将在 2024 年占据市场最大的收益占有率。
• 根据最终用途，市场分为製药公司、生技公司和其他公司。
• 2024 年，北美生物标记发现外包服务业占据最大的市场占有率，为 43.96%。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章生物标记发现外包服务市场变数、趋势与范围

• 市场体系展望
  • 母市场展望
  • 相关/支持市场展望
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 科技
  • 将人工智慧和巨量资料融入生物标记研究
  • 体学技术
  • 生物资讯学和云端运算的作用
• 定价模式分析
• 价值链分析
• 市场分析工具
  • 波特五力分析
  • PESTEL 与 SWOT 分析
  • COVID-19影响分析

第 4 章生物标记发现外包服务市场：按生物标记类型进行的估计和趋势分析

• 生物标誌物发现外包服务市场，按生物标记类型：细分仪表板
• 生物标记发现外包服务市场，依生物标记类型划分：变异分析
• 依生物标记类型，2018-2030 年
• 预测性生物标记
• 预后生物标记
• 安全生物标记
• 委託端点

第 5 章生物标记发现外包服务市场：按治疗领域进行的估计和趋势分析

• 生物标记发现外包服务市场（按治疗领域）：细分仪表板
• 生物标记发现外包服务市场（按治疗领域）：差异分析
• 依治疗领域，2018-2030 年
• 肿瘤学
• 神经病学
• 心臟病学
• 自体免疫疾病
• 其他的

第六章生物标记发现外包服务市场：各阶段的估计与趋势分析

• 生物标记发现外包服务市场（按阶段）：细分仪表板
• 生物标记发现外包服务市场（按阶段）：波动分析
• 按阶段划分，2018 - 2030 年
• 生物标誌物识别
• 生物标记检验
• 生物标记分析
• 生物标记组开发
• 生物标誌物选择

第七章生物标记发现外包服务市场：按最终用途的估计和趋势分析

• 生物标誌物发现外包服务市场，按最终用途：细分仪表板
• 生物标记发现外包服务市场，依最终用途划分：变异分析
• 按最终用途划分，2018-2030 年
• 製药公司
• 生技公司
• 其他的

第 8 章生物标记发现外包服务市场：按地区估计和趋势分析

• 2024 年及 2030 年区域市场占有率分析
• 区域市场仪表板
• 全球区域市场概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 瑞典
  • 丹麦
  • 挪威
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 泰国
  • 韩国
  • 澳洲
• 拉丁美洲
  • 巴西
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 科威特

第九章 竞争格局

• 市场参与企业分类
  • 市场领导者
  • 新参与企业
• 公司市场占有率/估值分析，2024 年
• 公司简介
  • Laboratory Corporation of America Holdings
  • Charles River Laboratories
  • Eurofins Scientific
  • Celerion
  • ICON plc.
  • Parexel International（MA）Corporation
  • Proteome Sciences
  • GHO Capital
  • Thermo Fisher Scientific Inc.
  • Evotec

Biomarker Discovery Outsourcing Services Market Growth & Trends:

The global biomarker discovery outsourcing services market size is expected to reach USD 41.27 billion by 2030, growing at a CAGR of 19.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The expansion of outsourced biomarker research, attributed to the increased utilization of biomarkers in clinical trials and the accelerating level of outsourcing undertaken by pharmaceutical firms are key growth factors for this market.

Furthermore, increasing adoption of liquid biopsies is expected to drive the market growth. Liquid biopsies, which involve the analysis of biomarkers in bodily fluids like blood, urine, and cerebrospinal fluid, offer several advantages over traditional tissue biopsies, such as being less invasive and providing real-time information. As a result, the adoption of liquid biopsies has been growing rapidly, and this trend directly impacts the demand for biomarker discovery outsourcing services.

Advancements in omics technologies are expected to drive market growth in the coming years. Progress in genomics, proteomics, metabolomics, and other omics technologies has enabled the identification of novel biomarkers.Integrating data from many omics disciplines can often be advantageous for biomarker identification. This all-encompassing approach enables a more thorough comprehension of complex disorders and can result in identifying reliable, multidimensional biomarkers.Outsourcing services specializing in multi-omics data integration offer valuable expertise in this area.

An increase in drug development and clinical trials is a major contributing factor to the market growth. Biomarkers play a crucial role in drug development, helping pharmaceutical companies identify suitable drug targets, streamline clinical trial processes, and select patient populations for trials.As of 2023, the global clinical trial landscape boasts 452,604 registered trials on ClinicalTrials.gov, with 64,838 actively enrolling participants. This reflects a notable surge compared to the roughly 365,000 registered trials documented in early 2021, underscoring the robust and ongoing growth within the field of clinical research.

Biomarker Discovery Outsourcing Services Market Report Highlights:

• Based on biomarker type, the surrogate endpoints segment accounted for the largest revenue share of 54.88% in 2024.
• Based on therapeutic areas, the market includes oncology, neurology, cardiology, autoimmune diseases, and others.
• Based on the discovery phase, in 2024, the biomarker identification segment accounted for the largest revenue share in the market.
• Based on end use, the market is segmented into pharmaceutical companies, biotechnology companies, and others.
• The biomarker discovery outsourcing services industry in North America accounted for the largest market share of 43.96% in 2024.

Table of Contents

Chapter 1. Research Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Regional Scope
  • 1.1.2. Estimates and Forecast Timeline
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information Or Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity Flow Analysis
  • 1.7.2. Parent Market Analysis
• 1.8. List Of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Biomarker Discovery Outsourcing Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing Demand for Biomarkers in Drug Development
    • 3.2.1.2. Expanding R&D Investment in Biopharmaceuticals
    • 3.2.1.3. Rising Prevalence of Chronic and Infectious Diseases
    • 3.2.1.4. Increasing focus on personalized medicine and targeted therapies
    • 3.2.1.5. Advancements in Omics Technologies
    • 3.2.1.6. Increasing Role of CROs and CDMOs Owing to Cost and Time Efficiency
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Limited Reproducibility & Validation Challenges
    • 3.2.2.2. High Cost of Biomarker Discovery & Validation
    • 3.2.2.3. Data Privacy & Security Concerns
• 3.3. Technology Landscape
  • 3.3.1. Integration of AI and Big Data in Biomarker Research
  • 3.3.2. Omics Technologies
  • 3.3.3. Role of Bioinformatics & Cloud Computing
• 3.4. Pricing Model Analysis
• 3.5. Value Chain Analysis
• 3.6. Market Analysis Tools
  • 3.6.1. Porter's Five Forces Analysis
  • 3.6.2. PESTEL by SWOT Analysis
  • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Biomarker Discovery Outsourcing Services Market: Biomarker Type Estimates & Trend Analysis

• 4.1. Biomarker Discovery Outsourcing Services Market, By Biomarker Type: Segment Dashboard
• 4.2. Biomarker Discovery Outsourcing Services Market, By Biomarker Type: Movement Analysis
• 4.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, By Biomarker Type, 2018 - 2030 (USD Million)
• 4.4. Predictive Biomarkers
  • 4.4.1. Predictive Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Prognostic Biomarkers
  • 4.5.1. Prognostic Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Safety Biomarkers
  • 4.6.1. Safety Biomarkers Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Surrogate Endpoints
  • 4.7.1. Surrogate Endpoints Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Biomarker Discovery Outsourcing Services Market: Therapeutic Area Estimates & Trend Analysis

• 5.1. Biomarker Discovery Outsourcing Services Market, By Therapeutic Area: Segment Dashboard
• 5.2. Biomarker Discovery Outsourcing Services Market, By Therapeutic Area: Movement Analysis
• 5.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030 (USD Million)
• 5.4. Oncology
  • 5.4.1. Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Neurology
  • 5.5.1. Neurology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Cardiology
  • 5.6.1. Cardiology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Autoimmune Diseases
  • 5.7.1. Autoimmune Diseases Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Other Therapeutic Area
  • 5.8.1. Other Therapeutic Area Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Biomarker Discovery Outsourcing Services Market: Discovery Phase Estimates & Trend Analysis

• 6.1. Biomarker Discovery Outsourcing Services Market, By Discovery Phase: Segment Dashboard
• 6.2. Biomarker Discovery Outsourcing Services Market, By Discovery Phase: Movement Analysis
• 6.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, By Discovery Phase, 2018 - 2030 (USD Million)
• 6.4. Biomarker Identification
  • 6.4.1. Biomarker Identification Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Biomarker Validation
  • 6.5.1. Biomarker Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Biomarker Profiling
  • 6.6.1. Biomarker Profiling Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Biomarker Panel Development
  • 6.7.1. Biomarker Panel Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Biomarker Selection
  • 6.8.1. Biomarker Selection Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Biomarker Discovery Outsourcing Services Market: End Use Estimates & Trend Analysis

• 7.1. Biomarker Discovery Outsourcing Services Market, By End Use: Segment Dashboard
• 7.2. Biomarker Discovery Outsourcing Services Market, By End Use: Movement Analysis
• 7.3. Biomarker Discovery Outsourcing Services Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
• 7.4. Pharmaceutical Companies
  • 7.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Biotechnology Companies
  • 7.5.1. Biotechnology Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Biomarker Discovery Outsourcing Services Market: Regional Estimates & Trend Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2030
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. North America
  • 8.4.1. North America Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Sweden
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Denmark
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competitive Scenario
    • 8.5.8.3. Regulatory Framework
    • 8.5.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competitive Scenario
    • 8.5.9.3. Regulatory Framework
    • 8.5.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Thailand
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Australia
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. MEA
  • 8.8.1. MEA Market Estimates and Forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competitive Scenario
    • 8.8.4.3. Regulatory Framework
    • 8.8.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competitive Scenario
    • 8.8.5.3. Regulatory Framework
    • 8.8.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
  • 9.1.1. Market Leaders
  • 9.1.2. Emerging Players
• 9.2. Company Market Share/Assessment Analysis, 2024
• 9.3. Company Profiles
  • 9.3.1. Laboratory Corporation of America Holdings
    • 9.3.1.1. Company Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Service Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Charles River Laboratories
    • 9.3.2.1. Company Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Service Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Eurofins Scientific
    • 9.3.3.1. Company Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Service Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Celerion
    • 9.3.4.1. Company Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Service Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. ICON plc.
    • 9.3.5.1. Company Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Service Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Parexel International (MA) Corporation
    • 9.3.6.1. Company Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Service Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Proteome Sciences
    • 9.3.7.1. Company Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Service Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. GHO Capital
    • 9.3.8.1. Company Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Service Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Thermo Fisher Scientific Inc.
    • 9.3.9.1. Company Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Service Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Evotec
    • 9.3.10.1. Company Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Service Benchmarking
    • 9.3.10.4. Strategic Initiatives

List of Tables

• Table. 1 List of Secondary Sources
• Table. 2 List of Abbreviations
• Table. 3 Global Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 4 Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 5 Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 6 Global Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 7 Global Biomarker Discovery Outsourcing Services Market, by Region, 2018 - 2030 (USD Million)
• Table. 8 North America Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
• Table. 9 North America Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 10 North America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 11 North America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 12 North America Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 13 U.S. Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 14 U.S. Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 15 U.S. Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 16 U.S. Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 17 Canada Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 18 Canada Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 19 Canada Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 20 Canada Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 21 Mexico Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 22 Mexico Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 23 Mexico Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 24 Mexico Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 25 Europe Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
• Table. 26 Europe Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 27 Europe Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 28 Europe Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 29 Europe Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 30 Germany Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 31 Germany Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 32 Germany Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 33 Germany Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 34 UK Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 35 UK Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 36 UK Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 37 UK Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 38 France Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 39 France Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 40 France Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 41 France Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 42 Italy Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 43 Italy Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 44 Italy Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 45 Italy Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 46 Spain Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 47 Spain Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 48 Spain Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 49 Spain Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 50 Denmark Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 51 Denmark Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 52 Denmark Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 53 Denmark Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 54 Sweden Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 55 Sweden Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 56 Sweden Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 57 Sweden Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 58 Norway Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 59 Norway Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 60 Norway Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 61 Norway Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 62 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
• Table. 63 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 64 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 65 Asia Pacific Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 66 Asia Pacific Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 67 China Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 68 China Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 69 China Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 70 China Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 71 Japan Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 72 Japan Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 73 Japan Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 74 Japan Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 75 India Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 76 India Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 77 India Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 78 India Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 79 South Korea Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 80 South Korea Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 81 South Korea Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 82 South Korea Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 83 Australia Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 84 Australia Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 85 Australia Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 86 Australia Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 87 Thailand Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 88 Thailand Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 89 Thailand Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 90 Thailand Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 91 Latin America Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
• Table. 92 Latin America Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 93 Latin America Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 94 Latin America Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 95 Latin America Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 96 Brazil Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 97 Brazil Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 98 Brazil Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 99 Brazil Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 100 Argentina Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 101 Argentina Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 102 Argentina Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 103 Argentina Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 104 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Country, 2018 - 2030 (USD Million)
• Table. 105 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 106 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 107 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 108 Middle East & Africa Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 109 South Africa Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 110 South Africa Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 111 South Africa Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 112 South Africa Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 113 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 114 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 115 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 116 Saudi Arabia Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 117 UAE Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 118 UAE Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 119 UAE Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 120 UAE Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)
• Table. 121 Kuwait Biomarker Discovery Outsourcing Services Market, by Biomarker Type, 2018 - 2030 (USD Million)
• Table. 122 Kuwait Biomarker Discovery Outsourcing Services Market, by Therapeutic Area, 2018 - 2030 (USD Million)
• Table. 123 Kuwait Biomarker Discovery Outsourcing Services Market, by Discovery Phase, 2018 - 2030 (USD Million)
• Table. 124 Kuwait Biomarker Discovery Outsourcing Services Market, by End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Biomarker Discovery Outsourcing Services, Market Segmentation
• Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 Regional Marketplace: Key Takeaways
• Fig. 12 Global Biomarker Discovery Outsourcing Services, for Predictive Biomarkers, 2018 - 2030 (USD Million)
• Fig. 13 Global Biomarker Discovery Outsourcing Services, for Prognostic Biomarkers, 2018 - 2030 (USD Million)
• Fig. 14 Global Biomarker Discovery Outsourcing Services, for Safety Biomarkers, 2018 - 2030 (USD Million)
• Fig. 15 Global Biomarker Discovery Outsourcing Services, for Surrogate Endpoints, 2018 - 2030 (USD Million)
• Fig. 16 Global Biomarker Discovery Outsourcing Services, for Oncology, 2018 - 2030 (USD Million)
• Fig. 17 Global Biomarker Discovery Outsourcing Services, for Neurology, 2018 - 2030 (USD Million)
• Fig. 18 Global Biomarker Discovery Outsourcing Services, for Cardiology, 2018 - 2030 (USD Million)
• Fig. 19 Global Biomarker Discovery Outsourcing Services, for Autoimmune Diseases, 2018 - 2030 (USD Million)
• Fig. 20 Global Biomarker Discovery Outsourcing Services, for Other Therapeutic Area, 2018 - 2030 (USD Million)
• Fig. 21 Global Biomarker Discovery Outsourcing Services, for Biomarker Identification, 2018 - 2030 (USD Million)
• Fig. 22 Global Biomarker Discovery Outsourcing Services, for Biomarker Validation, 2018 - 2030 (USD Million)
• Fig. 23 Global Biomarker Discovery Outsourcing Services, for Biomarker Profiling, 2018 - 2030 (USD Million)
• Fig. 24 Global Biomarker Discovery Outsourcing Services, for Biomarker Panel Development, 2018 - 2030 (USD Million)
• Fig. 25 Global Biomarker Discovery Outsourcing Services, for Biomarker Selection, 2018 - 2030 (USD Million)
• Fig. 26 Global Biomarker Discovery Outsourcing Services, for Pharmaceutical Companies, 2018 - 2030 (USD Million)
• Fig. 27 Global Biomarker Discovery Outsourcing Services, for Biotechnology Companies, 2018 - 2030 (USD Million)
• Fig. 28 Global Biomarker Discovery Outsourcing Services, for Other End Use, 2018 - 2030 (USD Million)
• Fig. 29 Regional Outlook, 2024 & 2030
• Fig. 30 North America Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 31 U.S. Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 32 Canada Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 33 Mexico Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Europe Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 35 UK Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Germany Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 37 France Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Italy Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Spain Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Denmark Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Sweden Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Norway Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Asia Pacific Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 44 India Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 45 China Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Japan Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 47 South Korea Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Australia Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Thailand Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Latin America Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Brazil Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Argentina Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 53 MEA Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 54 South Africa Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Saudi Arabia Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 56 UAE Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Kuwait Biomarker Discovery Outsourcing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)